ResMed Inc. (RMD)

Market Cap	34.12B
Revenue (ttm)	4.93B
Net Income (ttm)	1.25B
Shares Out	146.87M
EPS (ttm)	8.47
PE Ratio	27.43
Forward PE	23.38
Dividend	$2.12 (0.91%)
Ex-Dividend Date	Feb 13, 2025

Volume	35,480
Open	232.72
Previous Close	232.79
Day's Range	231.48 - 232.66
52-Week Range	170.56 - 263.05
Beta	0.70
Analysts	Buy
Price Target	250.67 (+7.89%)
Earnings Date	Jan 30, 2025

About RMD

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Jun 2, 1995
• Employees: 9,980
• Stock Exchange: NYSE
• Ticker Symbol: RMD
• Website: https://www.resmed.com

Financial Performance

In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.

Analyst Forecast

According to 12 analysts, the average rating for RMD stock is "Buy." The 12-month stock price forecast is $250.67, which is an increase of 7.89% from the latest price.

Price Target

$250.67

(7.89% upside)

Analyst Consensus: Buy